Stem Cell Related Stocks Spiking on Reports Obama to Lift 8-Yr Ban on Embryonic Research (STEM, CYTX, PSTI, ASTM, GERN)
More News related to ASTM
- Updates and Results From Aastrom's Vascular Program Presented at an American Heart Association Satellite Symposium
- Interim Results From Aastrom's IMPACT-DCM Cardiac Trial Presented at The American Heart Association Meeting
- Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.com
- Aastrom to Initiate Second Phase II Clinical Trial for Treatment of Severe Chronic Heart Failure
- Aastrom Biosciences (ASTM) Reports a Q1 Loss
More News related to CYTX
- Cytori Completes Enrollment in International Breast Cancer Reconstruction Study; Interim Data to Be Presented Dec. 12 at San Antonio Breast Cancer Symposium
- Cytori Reports 3rd Quarter 2009 Financial Results
- Trading Radar for 11/09: Dish Network (DISH), Rockwell (ROK), Priceline.com (PCLN), MBIA (MBI), Ticketmaster (TKTM) Report
- Cytori Therapeutics to Webcast Third Quarter Financial Results on November 9, 2009
- Cytori to Webcast Presentation at the 2009 BIOCOM Investor Conference on October 27
More News related to GERN
- Geron (GERN) Presents Interim Data from Imetelstat at AACR-NCI-EORTC Int. Conference
- Geron Presents Interim Clinical Data on Its Telomerase Inhibitor Drug at AACR-NCI-EORTC
- Geron to Present at LCM Healthcare Conference
- Trading Outlook for StemCells Inc. Issued by InvestorSoup.com
- Geron Corp. (GERN) Reports that hESC-Derived Oligodendrocyte Progenitor Cells Reduced Cervical Spinal Cord Injury
More News related to Insiders' Blog
- Pres. Obama's Afghanistan Exit Plan May Boost Some Defensive Stocks - CNBC
- Apple (AAPL) Investors Show Nervousness On Speculation T-Mobile Could Be Next iPhone Carrier
- Murdoch Shoots Down Rumors of News Corp. (NWS) De-Listing from Google (GOOG) and Joining Microsoft's (MSFT) Bing
- Positives Seen On BioCryst (BCRX) After Peramivir Granted Priority Review In Japan
- Most Automakers Report a Rise in November Sales (F, TM, GM, more)
Any stock related to stem cell research is surging today following rumors that President Obama is expected to issue an executive order lifting an 8-year ban on embryonic stem cell research.
StemCells (Nasdaq: STEM) is leading the group higher, up about 18% from Friday's close. The stock most recently traded at $2.49. Elsewhere in the sector: Cytori Therapeutics (Nasdaq: CYTX) up 10.4% to $4.25, Pluristem Therapeutics (Nasdaq: PSTI) up 14.7% to $1.33 and Aastrom Biosciences (Nasdaq: ASTM) is up 12.6% to $0.58. Meanwhile, recent high-flyer Geron (Nasdaq: GERN) is only modestly higher today, currently up 3.8% to $6.62.
Related Categories
Insiders' BlogMomentum Movers
Stocks Mentioned
+0.01
-0.03Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
